专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20060025006A1 Cable retaining system 审中-公开
标题翻译：电缆固定系统
公开(公告)号：US20060025006A1
公开(公告)日：2006-02-02
申请号：US11184479
申请日：2005-07-19
申请人： David Powell , Alan Brown , William Mackenzie
发明人： David Powell , Alan Brown , William Mackenzie
IPC分类号： H01R13/58
CPC分类号： H01R13/5812
摘要： A retaining system (1) that retains the front portion of a cable (7) in a connector housing (3). A sleeve device (21) has a base (25) with a hole (34) through which the cable extends, and has a pair of arms (27) with part-cylindrical inner surfaces that press against the cable to grip it. The arms have rear ends with recess (31). When the sleeve device is pushed fully forward into the connector housing, a bridging device (23) is pushed through an opening (15) into the housing. Legs (37) of the bridging element are inserted into the arm recesses (31) and prevent pull-out of the sleeve device and cable.
摘要翻译：一种将电缆（7）的前部保持在连接器壳体（3）中的保持系统（1）。套筒装置（21）具有带孔（34）的基座（25），电缆延伸通过该基座（25），并具有一对具有部分圆柱形内表面的臂（27），该部分圆柱形内表面压靠电缆以夹持它。臂具有带凹部（31）的后端。当套筒装置完全向前推入连接器壳体中时，桥接装置（23）被推动通过开口（15）进入壳体。桥接元件的腿部（37）插入到臂凹部（31）中，并且防止套筒装置和电缆的拉出。

2. 发明申请

US20140178920A1 SOLID SUPPORT FOR ENDOTHELIAL CELL GROWTH 审中-公开
标题翻译：固体支持内皮细胞生长
公开(公告)号：US20140178920A1
公开(公告)日：2014-06-26
申请号：US14234325
申请日：2012-07-30
申请人： George Burke , Brian Meenan , Alan Brown
发明人： George Burke , Brian Meenan , Alan Brown
IPC分类号： G01N33/50 , B29C59/02 , C12N5/071
CPC分类号： G01N33/5044 , B29C59/022 , C12N5/0068 , C12N5/069 , C12N2533/30 , C12N2535/10
摘要： The invention relates to a solid support suitable for supporting endothelial cell growth which has one or more regions of microstructure incorporated onto the growing surface thereof as well as to such supports having endothelial cells attached thereto. The invention further relates to methods of culturing endothelial cells and directing tubule formation using these supports.
摘要翻译：本发明涉及适合于支持内皮细胞生长的固体支持物，其具有结合到其生长表面上的一个或多个微结构区域，以及具有附着于其上的内皮细胞的这种支持物。本发明还涉及使用这些载体培养内皮细胞和引导小管形成的方法。

3. 发明申请

US20080311317A1 Substrates 有权
标题翻译：基材
公开(公告)号：US20080311317A1
公开(公告)日：2008-12-18
申请号：US12222839
申请日：2008-08-18
申请人： Roland Isherwood , James Snelling , Alan Brown
发明人： Roland Isherwood , James Snelling , Alan Brown
IPC分类号： B44F1/12 , B44F1/14 , B32B3/02 , B42D15/00
CPC分类号： B42D25/351 , B42D25/00 , B42D25/355 , B42D25/369 , B42D25/47 , B42D2033/04 , B42D2033/16 , D21H21/42 , D21H21/48 , G06K19/06196 , Y10T428/24628 , Y10T428/24802 , Y10T428/24868 , Y10T428/24876
摘要： The invention relates to improvements in substrates and in particular to new substrates having magnetic and visual security features, which provide security against imitation. A security substrate comprising a transparent polymer carrier layer bearing indicia formed from a plurality of opaque and non-opaque regions and a transparent magnetic layer supported by the carrier layer containing a distribution of particles of a hard magnetic material of a size and distributed in a concentration at which the magnetic layer remains transparent.
摘要翻译：本发明涉及衬底的改进，特别涉及具有磁性和视觉安全特征的新型衬底，其提供了针对模仿的安全性。一种安全基板，包括由多个不透明区域和非不透明区域形成的带有标记的透明聚合物载体层和由载体层支撑的透明磁性层，所述透明磁性层含有尺寸分布为浓度的硬磁性材料颗粒的分布磁层保持透明。

4. 发明申请

US20070245313A1 Failure tagging 审中-公开
标题翻译：失败标记
公开(公告)号：US20070245313A1
公开(公告)日：2007-10-18
申请号：US11404679
申请日：2006-04-14
申请人： Donald Hardy , Alan Brown , Curtis Anderson , Jared Wilson , Loren Merriman , Richard Wright , Xun Zhang
发明人： Donald Hardy , Alan Brown , Curtis Anderson , Jared Wilson , Loren Merriman , Richard Wright , Xun Zhang
IPC分类号： G06F9/44
CPC分类号： G06F11/3688
摘要： Failure tagging may be provided. A plurality of tests may be initiated on a program module and output resulting from the plurality of tests may be received. The output resulting from the plurality of tests may be determined to comprise at least one failure. The at least one failure may comprise an unknown failure or a known failure. Results of the plurality of tests indicating the failure may be transmitted. In addition, a request to stop one or more of a plurality of computers on a failure may be received when one of the plurality of computers encounters the failure. In addition, the program module may be transmitted to the plurality of computers configured to run tests on the program module. The one of the plurality of computers may be stopped on the failure when the one of the plurality of computers encounters the failure identified by the request.
摘要翻译：可能会提供故障标记。可以在程序模块上启动多个测试，并且可以接收由多个测试得到的输出。由多个测试产生的输出可以被确定为包括至少一个故障。至少一个故障可能包括未知故障或已知故障。可以发送指示故障的多个测试的结果。此外，当多个计算机中的一个计算机遇到故障时，可以接收到在故障时停止多个计算机中的一个或多个的请求。此外，程序模块可以被发送到被配置为在程序模块上运行测试的多个计算机。当多个计算机中的一个计算机遇到由请求识别的故障时，多个计算机中的一个可以在故障时停止。

5. 发明申请

US20060160786A1 Substituted triazole derivatives as oxytocin antagonists 有权
公开(公告)号：US20060160786A1
公开(公告)日：2006-07-20
申请号：US11335940
申请日：2006-01-20
申请人： Alan Brown , Andrew Calabrese , David Ellis
发明人： Alan Brown , Andrew Calabrese , David Ellis
IPC分类号： A61K31/454 , A61K31/4439 , C07D403/14
CPC分类号： C07D401/14
摘要： The present invention relates to substituted triazoles of formula (I), uses thereof, processes for the preparation thereof and compositions containing said compounds. These inhibitors have utility in a variety of therapeutic areas including sexual dysfunction.

6. 发明申请

US20050014789A1 Amide derivatives as selective serotonin re-uptake inhibitors 审中-公开
标题翻译：酰胺衍生物作为选择性5-羟色胺再摄取抑制剂
公开(公告)号：US20050014789A1
公开(公告)日：2005-01-20
申请号：US10865408
申请日：2004-06-10
申请人： Mark Andrews , Alan Brown , David Fradet , David Gordon , Mark Lansdell , Malcolm MacKenny
发明人： Mark Andrews , Alan Brown , David Fradet , David Gordon , Mark Lansdell , Malcolm MacKenny
IPC分类号： A61P25/24 , A61P25/30 , C07D207/14 , C07D211/58 , C07D401/12 , A61K31/445 , A61K31/40 , C07D207/10 , C07D211/56
CPC分类号： C07D401/12 , C07D207/14 , C07D211/58
摘要： The present invention relates to compounds of formula (I), wherein R1 is selected from: (a) (C1-C6)alkyl, optionally substituted by 1-3 substituents, each independently selected from: (i) CF3, OH, (C1-C6)alkyl, (C3-C6)cycloalkyl, (C1-C6)alkoxy and halo. (ii) Phenyl, optionally fused with phenyl or cyclohexyl, said phenyl or fused phenyl optionally substituted with 1-3 groups selected from (C1-C6)alkyl, (C1-C6)alkyl ester, OH and halo; and (b) (C3-C6)cycloalkyl, optionally fused with (C5-C7)cycloalkyl, said cycloalkyl or fused cycloalkyl optionally substituted by OH, (C1-C6)alkyl, (C1-C6)alkoxy and halo. R2 is Phenyl, optionally fused to (C4-C6)cycloalkyl, phenyl or pyridyl, said phenyl or fused phenyl moiety optionally substituted with 1-3 groups each independently selected from (C1-C6)alkyl, (C1-C6)alkoxy, halo and OH; n is 1 to 2; and pharmaceutically acceptable salts, solvates or polymorphs thereof; With the proviso that when n is 2 and R1 is 2-(3,4-dimethoxylphenyl)-1-ethyl, 3,3-diphenyl-1-propyl or 2,4-difluorophenyl, then R2 cannot be 4-trifluoromethoxyphenyl, 2,4,6-trimethoxyphenyl, 4-acetoxyphenyl or 2,4-difluorophenyl; which are a class of selective serotonin re-uptake inhibitors (SSRIs).
摘要翻译：本发明涉及式（I）化合物，其中R 1选自：（a）任选被1-3个取代基取代的（C 1 -C 6）烷基，各自独立地选自：（i）CF 3，OH ，（C 1 -C 6）烷基，（C 3 -C 6）环烷基，（C 1 -C 6）烷氧基和卤素。（ii）苯基，任选地与苯基或环己基稠合，所述苯基或稠合苯基任选被1-3个选自（C 1 -C 6）烷基，（C 1 -C 6）烷基酯，OH和卤素的基团取代; 任选地与（C 5 -C 7）环烷基稠合的所述环烷基或任选被OH，（C 1 -C 6）烷基，（C 1 -C 6）烷氧基和卤素取代的稠合环烷基。 R 2是苯基，任选地与（C 1 -C 6）环烷基，苯基或吡啶基稠合，所述苯基或稠合苯基部分任选被1-3个基团独立地选自（C 1 -C 6）烷基，（C 1 -C 6）烷氧基，卤素和OH; n为1〜2; 及其药学上可接受的盐，溶剂化物或多晶型物; 条件是当n为2且R 1为2-（3,4-二甲氧基苯基）-1-乙基，3,3-二苯基-1-丙基或2,4-二氟苯基时，则R 2不能 4-三氟甲氧基苯基，2,4,6-三甲氧基苯基，4-乙酰氧基苯基或2,4-二氟苯基; 其是一类选择性5-羟色胺再摄取抑制剂（SSRI）。

7. 发明申请

US20050014763A1 2-Amino-pyridine derivatives useful for the treatment of diseases 失效
公开(公告)号：US20050014763A1
公开(公告)日：2005-01-20
申请号：US10860772
申请日：2004-06-03
申请人： Alan Brown , Charlotte Lane , Russell Lewthwaite
发明人： Alan Brown , Charlotte Lane , Russell Lewthwaite
IPC分类号： A61K31/4439 , A61K31/4709 , A61K31/496 , C07
CPC分类号： A61K31/4709 , A61K31/4439 , A61K31/496 , C07D213/73 , C07D401/04 , C07D401/12
摘要： The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.

8. 发明申请

US20070185078A1 Substituted triazole derivatives as oxytocin antagonists 审中-公开
标题翻译：取代的三唑衍生物作为催产素拮抗剂
公开(公告)号：US20070185078A1
公开(公告)日：2007-08-09
申请号：US11570199
申请日：2005-05-27
申请人： Alan Brown , Andrew Calabrese , David Ellis , Lesa Watson
发明人： Alan Brown , Andrew Calabrese , David Ellis , Lesa Watson
IPC分类号： A61K31/551 , A61K31/554 , C07D487/12 , C07D498/02
CPC分类号： C07D471/14 , C07D487/14 , C07D498/04
摘要： This invention relates to compounds of formula (I)
摘要翻译：本发明涉及式（I）化合物，

9. 发明申请

US20060039699A1 Countermeasures for idle pattern SRS interference in ethernet optical network systems 有权
公开(公告)号：US20060039699A1
公开(公告)日：2006-02-23
申请号：US11200873
申请日：2005-08-10
申请人： James Farmer , Alan Brown , John Kenny , Stephen Thomas
发明人： James Farmer , Alan Brown , John Kenny , Stephen Thomas
IPC分类号： H04J14/00
CPC分类号： H04J14/0227 , H04B10/2537 , H04J14/0226 , H04J14/0232 , H04J14/0247 , H04J14/0252 , H04J14/0282 , H04L2007/045
摘要： Optical networks as defined by the IEEE 802.3ah standard suffer from Stimulated Raman Scattering (SRS) that causes data transmission at a first optical wavelength to interfere with broadcast video transmission at a second optical wavelength in single mode optical fibers. The problem is exacerbated when data is not being transmitted across the network; and instead, an idle pattern transmission is being transmitted in order to keep the network synchronized. The repetitive nature of the idle pattern transmission leads to the SRS optical interference effect. This optical interference effect is mitigated when countermeasures are implemented to modify the idle pattern transmissions or to transmit random data in place of the idle pattern transmissions.

10. 发明申请

US20050234097A1 Compounds useful for the treatment of diseases 失效
标题翻译：可用于治疗疾病的化合物
公开(公告)号：US20050234097A1
公开(公告)日：2005-10-20
申请号：US11083265
申请日：2005-03-16
申请人： Alan Brown , Charlotte Lane , Paul Glossop , David Price , Russell Lewthwaite , Mark Bunnage , Kim James , Graham Lunn
发明人： Alan Brown , Charlotte Lane , Paul Glossop , David Price , Russell Lewthwaite , Mark Bunnage , Kim James , Graham Lunn
IPC分类号： A61K31/138 , A61K31/4035 , A61K31/47
CPC分类号： C07D217/06 , C07C237/20 , C07C237/30 , C07C237/32 , C07C237/34 , C07C237/36 , C07C311/46 , C07C323/42 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07C2601/18 , C07C2602/08 , C07C2603/74 , C07D213/40 , C07D235/14 , C07D239/26 , C07D295/088 , C07D295/13 , C07D295/26
摘要： The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.
摘要翻译：本发明涉及式（1）化合物以及制备用于制备含这些衍生物的组合物和用途的中间体的方法。根据本发明的化合物可用于许多疾病，病症和病症，特别是炎症，过敏和呼吸道疾病，病症和病症。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式